Recorded Chinese product: 三磷酸胞苷二钠注射液三磷酸胞苷二钠注射液

This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。

Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。

生产企业Manufacturer

主要成分Active Ingredients

药物知识说明

三磷酸胞苷二钠是一种在国家药监局注册认定的药品。该药品含有三磷酸胞苷二钠-6a6cd836等成分。

该药品关联的活性成分包括:三磷酸胞苷二钠Sanlin Suanbao Ganer Na。这些成分信息来自国家药监局数据库。

该药品标注的生产企业为:江西青峰药业有限公司Chinese legal name: 江西青峰药业有限公司。

您可以探索含有相同成分的其他药品:三磷酸胞苷二钠-6a6cd836成分药品。

本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。

Medicine Knowledge

This medicine (original name: 三磷酸胞苷二钠注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).

Active ingredients associated with this product: 三磷酸胞苷二钠Sanlin Suanbao Ganer Na.

Manufacturers recorded for this product: 江西青峰药业有限公司Chinese legal name: 江西青峰药业有限公司.

Explore other medicines containing the same ingredient: 三磷酸胞苷二钠 productsProducts containing this recorded ingredient.

Source: MedicineGraph authoritative database. Relationships derived from registered product information.

这是什么What is this

  • 通用名/品名Recorded product name: 三磷酸胞苷二钠注射液Recorded Chinese product: 三磷酸胞苷二钠注射液
  • 剂型Dosage form: 注射剂Injection
  • 规格Specification: 2ml:20mg2 mL:20 mg

本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.

主要成分Ingredients

生产企业Manufacturer

  • 江西青峰药业有限公司Chinese legal name: 江西青峰药业有限公司

注册信息NMPA approval number

  • 批准文号NMPA approval number: 国药准字H20043940

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.

  • 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
  • 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
  • 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.

本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.

English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.

NMPA approval number

国药准字H20043940

Manufacturer

Chinese legal name: 江西青峰药业有限公司 (domestically manufactured)

Indications

English translation unavailable. The original Chinese source label remains available below.

Dosage and administration

English translation unavailable. The original Chinese source label remains available below.

Adverse reactions

English translation unavailable. The original Chinese source label remains available below.

Contraindications

English translation unavailable. The original Chinese source label remains available below.

Precautions

English translation unavailable. The original Chinese source label remains available below.

Storage

English translation unavailable. The original Chinese source label remains available below.

Specification

English translation unavailable. The original Chinese source label remains available below.

中文说明书原文Original Chinese source label

批准文号

国药准字H20043940

生产企业

江西青峰药业有限公司(国产)

适应症

用于颅脑外伤后综合症及其后遗症的辅助治疗。

用法用量

肌内注射,一次20mg,一日1~2次(20~40mg);静脉滴注,20mg加入5%葡萄糖注射液或生理盐水250ml中,或者40mg加入5%葡萄糖注射液或生理盐水500ml中缓慢静脉滴注

不良反应

偶有发热、皮疹,停药后症状消失。极少数病人出现一过性轻度谷丙转氨酶升高,停药后恢复正常。本药对窦房结有明显抑制作用。

禁忌

1、病窦综合征、窦房结功能不全者禁用,缓慢性心律失常者禁用。 2、对本品过敏者禁用。

注意事项

1、严禁静脉推注。2、静脉滴注时,滴速不可过快,否则会引起兴奋、呼吸加快、头晕、头胀、胸闷及低血压等。  3、严重肝、肾功能不全者慎用。4、癫痫患者慎用。5、心肌梗死、脑出血急性期慎用。6、当药品性状发生改变时禁止使用。

贮藏

密闭,在凉暗处(不超过20℃)保存。

规格

2ml:20mg

证据Evidence

  • 批准文号: 国药准字H20043940
  • rights: 本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。

信息来源Source and scope

国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.

范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.